Disordered glycometabolism involved in pathogenesis of Kashin-Beck disease, an endemic osteoarthritis in China

Experimental Cell Research

Volumn 326, Issue 2, 2014, Pages 240-250

  Wu, Cuiyan ^a,b,c   Lei, Ronghui ^a,b,c   Tiainen, Mika ^d   Wu, Shixun ^a,b,c   Zhang, Qiang ^e   Pei, Fuxing ^f   Guo, Xiong ^a,b,c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING HOSPITAL   (China)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e Plague Prevention and Control Department Qinghai Institute for Endemic Diseases Prevention and Control   (China)

^f SICHUAN UNIVERSITY   (China)

Author keywords

Chondrocyte; Glycometabolism; Kashin Beck disease; Metabolomics; Serum

Indexed keywords

AGGRECAN; ALANINE; CITRIC ACID; COLLAGEN TYPE 1; GLUCOSE; GLUTAMIC ACID; GLYCINE; ISOLEUCINE; LACTIC ACID; LEUCINE; MESSENGER RNA; N ACETYLGLUCOSAMINE; PHOSPHATIDYLCHOLINE; REACTIVE OXYGEN METABOLITE; THREONINE; TUMOR NECROSIS FACTOR ALPHA; VALINE;

ADULT; AMINO ACID METABOLISM; APOPTOSIS; ARTICLE; CARBOHYDRATE METABOLISM; CARTILAGE CELL; CELL DAMAGE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOMETABOLISM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KASHIN BECK DISEASE; LACTATE BLOOD LEVEL; MALE; METABOLOMICS; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE;

CHONDROCYTE; GLYCOMETABOLISM; KASHIN-BECK DISEASE; METABOLOMICS; SERUM;

AGED; AGGRECANS; CASE-CONTROL STUDIES; CHINA; CHONDROCYTES; COLLAGEN TYPE II; FEMALE; GLUCOSE; GLYCOGEN; HUMANS; KASHIN-BECK DISEASE; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; MIDDLE AGED; OSTEOARTHRITIS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904646753     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.04.019     Document Type: Article

References (44)

1. Hinsenkamp M. Kashin-Beck disease. Int. Orthop. 2001, 25:133.
2. Yamamuro T. Kashin-Beck disease: a historical overview. Int. Orthop. 2001, 25:134-137.
3. Guo X., Zuo H., Cao C.X., Zhang Y., Geng D., Zhang Z.T., Zhang Y.G., von der Mark K., von der Mark H. Abnormal expression of Col X, PTHrP, TGF-beta, bFGF, and VEGF in cartilage with Kashin-Beck disease. J. Bone Miner. Metab. 2006, 24:319-328.
4. Sudre P., Mathieu F. Kashin-Beck disease: from etiology to prevention or from prevention to etiology?. Int. Orthop. 2001, 25:175-179.
5. Martin J.A., Buckwalter J.A. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002, 3:257-264.
6. Pasteels J., Liu F.-D., Hinsenkamp M., Rooze M., Mathieu F., Perlmutter N. Histology of Kashin-Beck lesions. Int. Orthop. 2001, 25:151-153.
7. Aspden R.M., Scheven B.A., Hutchison J.D. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. The Lancet 2001, 357:1118-1120.
8. Velasquez M.T., Katz J.D. Osteoarthritis: another component of metabolic syndrome?. Metab. Syndr. Relat. Disord. 2010, 8:295-305.
9. Wang W.Z., Guo X., Duan C., Ma W.J., Zhang Y.G., Xu P., Gao Z.Q., Wang Z.F., Yan H., Zhang Y.F., Yu Y.X., Chen J.C., Lammi M.J. Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthr. Cartil. 2009, 17:83-90.
10. Duan C., Guo X., Zhang X.D., Yu H.J., Yan H., Gao Y., Ma W.J., Gao Z.Q., Xu P., Lammi M. Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to northwestern China, Kashin-Beck disease. Arthritis Rheum. 2010, 62:771-780.
11. Guo X. Molecular biological mechanism on chondronecrosis in cartilage with Kashin-Beck disease. J. Xi'an Jiaotong Univ. Med. Sci. 2005, 26:201-204.
12. Mobasheri A., Vannucci S.J., Bondy C.A., Carter S.D., Innes J.F., Arteaga M.F., Trujillo E., Ferraz I., Shakibaei M., Martin-Vasallo P. Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol. Histopathol. 2002, 17:1239-1267.
13. Murata M., Yudoh K., Masuko K. The potential role of vascular endothelial growth factor (VEGF) in cartilage - How the angiogenic factor could be involved in the pathogenesis of osteoarthritis?. Osteoarthr. Cartil. 2008, 16:279-286.
14. Goldring M.B. Osteoarthritis and cartilage: the role of cytokines. Curr. Rheumatol. Rep. 2000, 2:459-465.
15. Huffman K.M., Bowers J.R., Dailiana Z., Huebner J.L., Urbaniak J.R., Kraus V.B. Synovial fluid metabolites in osteonecrosis. Rheumatology 2007, 46:523-528.
16. Lamers R., van Nesselrooij J.H.J., Kraus V.B., Jordan J.M., Renner J.B., Dragomir A.D., Luta G., van der Greef J., DeGroot J. Identification of an urinary metabolite profile associated with osteoarthritis. Osteoarthr. Cartil. 2005, 13:762-768.
17. 13C NMR spectroscopy. Bull. Chem. Soc. Ethiop. 2009, 23:211-221.
18. Saric J., Wang Y., Li J., Coen M., Utzinger J., Marchesi J.R., Keiser J., Veselkov K., Lindon J.C., Nicholson J.K., Holmes E. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J. Proteome Res. 2008, 7:352-360.
19. Bollard M.E., Stanley E.G., Lindon J.C., Nicholson J.K., Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 2005, 18:143-162.
20. Ma W.J., Guo X., Liu J.T., Liu R.Y., Hu J.W., Sun A.G., Yu Y.X., Lammi M.J. Proteomic changes in articular cartilage of human endemic osteoarthritis in China. Proteomics 2011, 11:2881-2890.
21. Liu J.T., Guo X., Ma W.J., Zhang Y.G., Xu P., Yao J.F., Bai Y.D. Mitochondrial function is altered in articular chondrocytes of an endemic osteoarthritis, Kashin-Beck disease. Osteoarthr. Cartil. 2010, 18:1218-1226.
22. D'Antona G., Ragni M., Cardile A., Tedesco L., Dossena M., Bruttini F., Caliaro F., Corsetti G., Bottinelli R., Carruba M.O. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab. 2010, 12:362-372.
23. Zhai G., Wang-Sattler R., Hart D.J., Arden N.K., Hakim A.J., Illig T., Spector T.D. Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis. Ann. Rheum. Dis. 2010, 69:1227-1231.
24. Peng A., Yang C.L., Rui H.F., Li H. Study on the pathogenic factors of Kashin-Beck disease. J. Toxicol. Environ. Health 1992, 35:79-90.
25. Perriello G., Jorde R., Nurjhan N., Stumvoll M., Dailey G., Jenssen T., Bier D.M., Gerich J.E. Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle. Am. J. Physiol.-Endocrinol. Metab. 1995, 269:E443-E450.
26. Tang X., Zhou Z., Shen B., Yang J., Kang P., Li J., Crook N., Li Q., Min L., Pei F. Serum levels of TNF-alpha, IL-1 beta, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China. Rheumatol. Int. 2012, 32:3503-3509.
27. Zhao Q.M., Guo X., Lai J.H., Tan W.H., Wang W.Z., Dang X.Q. Association of TNF-alpha and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population. Clin. Rheumatol. 2012, 31:1051-1057.
28. Nagai K., Fukushima T., Oike H., Kobori M. High glucose increases the expression of proinflammatory cytokines and secretion of TNFα and β-hexosaminidase in human mast cells. Eur. J. Pharmacol. 2012, 687:39-45.
29. Gonzalez Y., Herrera M.T., Soldevila G., Garcia-Garcia L., Fabian G., Martha Perez-Armendariz E., Bobadilla K., Guzman-Beltran S., Sada E., Torres M. High glucose concentrations induce TNF-alpha production through the down-regulation of CD33 in primary human monocytes. Bmc Immunol. 2012, 13.
30. Quan Y., Jiang C.T., Xue B., Zhu S.G., Wang X. High glucose stimulates TNF alpha and MCP-1 expression in rat microglia via ROS and NF-kappa B pathways. Acta Pharmacol. Sin. 2011, 32:188-193.
31. Porter M.H., Cutchins A., Fine J.B., Bai Y., Digirolamo M. Effects of TNF-α on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparations. J. Lab. Clin. Med. 2002, 139:140-146.
32. Lutz N.W., Tome M.E., Cozzone P.J. Early changes in glucose and phospholipid metabolism following apoptosis induction by IFN-γ/TNF-α in HT-29 cells. FEBS Lett. 2003, 544:123-128.
33. Rosa S.C., Goncalves J., Judas F., Mobasheri A., Lopes C., Mendes A.F. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res. Ther. 2009, 11.
34. Gao Z., Guo X., Duan C., Ma W., Xu P., Wang W., Chen J. Altered aggrecan synthesis and collagen expression profiles in chondrocytes from patients with Kashin-Beck disease and osteoarthritis. J. Int. Med. Res. 2012, 40:1325-1334.
35. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.-L., Flannery C.R., Peluso D., Kanki K., Yang Z. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
36. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front. Biosci. 2006, 11:529-543.
37. Yu T.Z., Robotham J.L., Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. USA 2006, 103:2653-2658.
38. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
39. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 2006, 212:167-178.
40. Fang S., Jin Y., Zheng H., Yan J., Cui Y., Bi H., Jia H., Zhang H., Wang Y., Na L. High glucose condition upregulated Txnip expression level in rat mesangial cells through ROS/MEK/MAPK pathway. Mol. Cell Biochem. 2011, 347:175-182.
41. Li S.Y., Sigmon V.K., Babcock S.A., Ren J. Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes. Life Sci. 2007, 80:1051-1056.
42. Tiku M.L., Gupta S., Deshmukh D.R. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic. Res. 1999, 30:395-405.
43. Henrotin Y., Bruckner P., Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr. Cartil. 2003, 11:747-755.
44. Quan Y., Jiang C.T., Xue B., Zhu S.G., Wang X. High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways. Acta Pharmacol. Sin. 2011, 32:188-193.